CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment

E. Mejstríková; O. Hrusak; M. J. Borowitz; J. A. Whitlock; B. Brethon; T. M. Trippett; G. Zugmaier; L. Gore; A. Von Stackelberg; F. Locatelli

doi:10.1038/s41408-017-0023-x

CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment

E. Mejstríková, O. Hrusak, M. J. Borowitz, J. A. Whitlock, B. Brethon, T. M. Trippett, G. Zugmaier, L. Gore, A. Von Stackelberg, F. Locatelli

School of Medicine

Research output: Contribution to journal › Letter › peer-review

42 Scopus citations

Original language	English (US)
Article number	1038
Journal	Blood cancer journal
Volume	7
Issue number	12
DOIs	https://doi.org/10.1038/s41408-017-0023-x
State	Published - Dec 1 2017

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-017-0023-x

Cite this

@article{60e255f139ca46cc9d3d4fc75bbb327f,

title = "CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment",

author = "E. Mejstr{\'i}kov{\'a} and O. Hrusak and Borowitz, {M. J.} and Whitlock, {J. A.} and B. Brethon and Trippett, {T. M.} and G. Zugmaier and L. Gore and {Von Stackelberg}, A. and F. Locatelli",

note = "Funding Information: We thank Cornelia Eckert, PhD (Charit{\'e} Campus Virchow, Berlin, Germany), for PCR methodology development; Cathy Tuglus, PhD (Amgen), for statistical support; and Janice Y Ahn, PhD (Amgen), and Alan Saltzman, PhD (Fishawack Communications, Conshohocken, PA), whose work was funded by Amgen, for medical writing support.",

year = "2017",

month = dec,

day = "1",

doi = "10.1038/s41408-017-0023-x",

language = "English (US)",

volume = "7",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment

AU - Mejstríková, E.

AU - Hrusak, O.

AU - Borowitz, M. J.

AU - Whitlock, J. A.

AU - Brethon, B.

AU - Trippett, T. M.

AU - Zugmaier, G.

AU - Gore, L.

AU - Von Stackelberg, A.

AU - Locatelli, F.

N1 - Funding Information: We thank Cornelia Eckert, PhD (Charité Campus Virchow, Berlin, Germany), for PCR methodology development; Cathy Tuglus, PhD (Amgen), for statistical support; and Janice Y Ahn, PhD (Amgen), and Alan Saltzman, PhD (Fishawack Communications, Conshohocken, PA), whose work was funded by Amgen, for medical writing support.

PY - 2017/12/1

Y1 - 2017/12/1

UR - http://www.scopus.com/inward/record.url?scp=85038625175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038625175&partnerID=8YFLogxK

U2 - 10.1038/s41408-017-0023-x

DO - 10.1038/s41408-017-0023-x

M3 - Letter

C2 - 29259173

AN - SCOPUS:85038625175

VL - 7

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 12

M1 - 1038

ER -

CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this